comparemela.com

Latest Breaking News On - மாறாக மேம்படுத்தப்பட்டது அல்ட்ராசவுண்ட் - Page 1 : comparemela.com

Blue Earth Diagnostics Supports Timely Consideration and Passage of the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 by U S Congress

Blue Earth Diagnostics Supports Timely Consideration and Passage of the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 by U S Congress
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Blue Earth Diagnostics Announces Axumin® (Fluciclovine F 18) Presentations at Upcoming 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

Blue Earth Diagnostics Announces Axumin® (Fluciclovine F 18) Presentations at Upcoming 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Blue Earth Diagnostics Announces Axumin (Fluciclovine F 18) Presentations at Upcoming 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today highlighted presentations at the 2021 American Society

Blue Earth Diagnostics: The Lancet Publishes Results of Axumin (Fluciclovine F 18) PET Imaging Study Demonstrating Improved Patient Outcomes in Patients with Recurrent Prostate Cancer

(0) - Treatment informed by Axumin PET imaging significantly improved event-free-survival for men with recurrent prostate cancer at three and four years - - Winship Cancer Institute of Emory University s EMPIRE-1 trial is first-of-its-kind randomized patient outcomes study of amino acid PET imaging in influencing a cancer control endpoint - Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, is pleased to share news of the publication of a study from researchers at Winship Cancer Institute of Emory University (Winship) evaluating Axumin (fluciclovine F 18) PET imaging in men with recurrent prostate cancer. The randomized, prospective study showed that Axumin-guided post-prostatectomy radiation therapy increased biochemical event-free survival rates in men with recurrent disease. Among 165 patients whose prostate cancer had returned following surgical removal of their prostate, 75.5% whose t

AI-for-COVID19: Predictive Diagnostics Platform Available to Global Scientific Community

Share this article MILAN, May 17, 2021 /PRNewswire/  The AIforCOVID Imaging Archive is a shared collection of images and clinical data for developing innovative Artificial Intelligence-based methods to predict clinical developments of SARS-CoV-2-related disease. This valuable tool enables the international scientific community to share radiological and clinical data and find innovative solutions to combat the disease. The AIforCOVID Imaging Archive, which is available, open access to the global scientific community at  https://aiforcovid.radiomica.it/, contains more than a thousand positive patient chest radiographic examinations carried out upon hospitalization. Each X-ray is associated with clinical information about the patient collected at that time.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.